Catalyst Pharmaceuticals Inc — Liquidità (NASDAQ:CPRX) | MetaTrader

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Flusso di cassa derivante dalle attività operative 45.03 M60.37 M116.05 M143.6 M239.81 M208.67 M 208.67 M Flussi di cassa derivanti dalle attività di investimento -5.01 M-11.02 M9.21 M-293.5 M-556 K-58 K -58 K Liquidità derivante dalle attività di finanziamento 701.93 K-8.14 M1.69 M-10.86 M140.66 M-16.99 M -16.99 M Liquidità libera 45.02 M59.35 M116.02 M143.37 M239.25 M208.61 M 208.61 M

Notizie

KYMR Stock Up as FDA Grants Fast Track Designation to Asthma Drug

RVMD Stock Rallies 41% on Positive Phase III Pancreatic Cancer Data

ALLO Rises on Strong MRD Clearance With Cema-Cel in ALPHA3 Study

Replimune Gets Second FDA CRL for Melanoma Drug BLA, Stock Crashes

SNY & REGN's Dupixent Gets EU Approval for Pediatric Use in Urticaria

IBRX Stock Rises 7% on Strong Q1 2026 Preliminary Results

KYMR Set to Earn Milestone Payment as GILD Secures License for KT-200

If You Invested $1000 in Catalyst Pharmaceutical 10 Years Ago, This Is How Much You'd Have Now

ACIU Stock Rallies 16.3% in a Week: Here's What You Need to Know

Recent Price Trend in Catalyst (CPRX) is Your Friend, Here's Why

Soleno Therapeutics Stock Rallies 56.4% in a Week: Here's Why

Insmed Ends Brinsupri Development in Skin Disease Post Study Failure